Sitewide
Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
Researchers have found that the breast cancer susceptibility gene, BRCA1, plays a significant role in nonsmall cell lung cancer. They told the European Cancer Conference in Barcelona that not only can it be used to predict outcome for patients with NSCLC, but it may also prove to be a valuable tool in choosing the best therapy for them.
Similar Articles On This Topic:
- 2 sets of genes predict response to lung cancer drug
- Oncogene AEG-1 strongly predicts response to erlotinib treatment in EGFR-mutant lung cancer
- Predicting breast cancer patient outcome: MUHC researchers identify new genes
- Proteins do not predict outcome of herceptin treatment in HER2-positive breast cancer
- Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
Popular Today:
Science 2.0:
- Scare Pic Of Earth Water Visual Framing Or Global Warming Wake Up Call
- Finding My Religion: The New Intersection Of Christianity And Environmentalism
- Organic Spinach Recalled Over Salmonella Concerns
- Modern Squid Ink Unchanged From Jurassic Times
- Skin Into Heart Tissue Using Induced Pluripotent Stem Cells
Recent Articles:
Read Us On Your Kindle:
Create Your Own Releases:
Post new comment